Related Experiment Video
Updated: Aug 11, 2025

09:46
Accessing the Cytotoxicity and Cell Response to Biomaterials
Published on: July 8, 2021
3.8K
[Evaluation of immunotoxicitiy in biomedical research and development]
Cathy Nguyen1, Lars Petter Jordheim2
1Univ Lyon, Université Claude Bernard Lyon 1, ISPB, F-69008 Lyon, France.
Biologie Aujourd'Hui
|February 6, 2023
Summary
Immunotoxicology assesses substance toxicity on the immune system using various methods. This review highlights key assays, like the T-cell Dependent Antibody Response (TDAR), and future ethical advancements, including cell models.
Area of Science:
- Immunotoxicology: Investigating the impact of external agents on immune system integrity and function.
- Regulatory Science: Adherence to established guidelines and texts within immunotoxicological studies.
- Biomedical Research: Application of diverse methodologies for evaluating immune system responses to toxicants.
Background:
- The field of immunotoxicology is crucial for understanding how substances affect immune health.
- Regulatory frameworks guide toxicological studies, ensuring standardized and reliable data collection.
- Assessing immune system function is vital for drug development and environmental safety.
Approach:
- Utilizing a range of in vitro, ex vivo, and in vivo techniques to study toxic effects.
- Employing observational studies to identify toxic effects and functional studies to elucidate mechanisms.
- Focusing on specific assays such as the T-cell Dependent Antibody Response (TDAR) for detailed analysis.
Key Points:
- Review of established and emerging assays for immunotoxicological assessment in R&D.
- Detailed examination of the T-cell Dependent Antibody Response (TDAR) assay.
- Exploration of future trends, emphasizing ethical considerations and reduced animal testing.
Conclusions:
- The development of novel cell models represents a significant step towards more ethical and efficient immunotoxicology testing.
- Continued refinement of testing methodologies is essential for accurate risk assessment.
- Integrating advanced techniques will enhance our understanding of immunotoxicological mechanisms and impacts.
Related Concept Videos
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K

